Cartilage Injury

6

Review clinical trials related to Cartilage Injury. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Long-term Outcome Evaluation of Patients Undergoing Autologous Chondrocyte Transplantation Delivered on Biomaterial

Chondro-Long study is prospective observational study for a long-term clinical evaluation (follow-up up to 25 years) in patients treated with autologous chondrocyte transplantation delivered on biomaterial for full-thickness chondral defects (Outerbridge grade III - IV) at the level of femoral condyles, trochlea, patella and tibial plateau. The aim of the study is to collect long-term clinical data from the case series of patients surgically treated from 1999 to 2006 with autologous chondrocyte transplantation delivered on biomaterial for full-thickness chondral defects (Outerbridge grade III - IV) or osteochondral defects at the level of femoral condyles, trochlea, patella, and tibial plateau. The objective of the study is to demonstrate the efficacy of this long-term cartilage regeneration technique (follow-up up to 25 years) in improving patient symptomatology and functional capacity

Participants needed: 200
Trial details
Age: 14-60Biological sex: AllType: ObservationalSponsor: Istituto Ortopedico RizzoliUpdated: Jul 1, 2026
Eligibility criteria

Full-thickness chondral defects (Outerbridge grade III - IV) and osteochondral d... [+2]

Patients no longer available

Status: Not yet recruiting

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Participants needed: 100
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Jay C. Buckey Jr.Updated: May 5, 2026
Eligibility criteria

Patients referred for HBOT with an emerging indication

Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothora... [+1]

Status: Recruiting

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.

Participants needed: 30
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Xinxiang Medical CollegeUpdated: May 4, 2026Locations: 1
Eligibility criteria

The patients' age ranges from 18 to 65 years old, and gender is not restricted; [+4]

The patient is extremely overweight, with a body mass index greater than 35; [+11]

Status: Recruiting

The Hyalex First-in-Human Study

The Hyalex First-in-Human Study is a prospective, multicenter, open-label, single-arm, 2-phase, first-in-human study to evaluate the safety and technical performance of the HYALEX Knee Cartilage System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment.

Participants needed: 15
Trial details
Age: 21-65Biological sex: AllType: InterventionalSponsor: Hyalex Orthopaedics, Inc.Updated: Jun 29, 2025Locations: 2
Eligibility criteria

Phase 1 [+14]

Phase 1 & 2 [+19]

Status: Recruiting

Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis

To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.

Participants needed: 300
Trial details
Age: 20-60Biological sex: AllType: InterventionalSponsor: Xijing HospitalUpdated: Apr 9, 2025Locations: 1
Eligibility criteria

The age range of the participants was 20 to 60 years old. Through a comprehensiv... [+2]

The platelet count or function exhibits significant abnormalities、Systemic infec... [+7]

Status: Not yet recruiting

CAsting and REhabilitation Versus Supervised Neglect for Osteochondral Lesions of the Talus in the Pediatric Population

Rationale: OCLs (osteochondral lesions) of the talus can be congenital or can occur after trauma or in patients with juvenile idiopathic arthritis (JIA). The main complaint of an OCL is pain during weightbearing activities. Therefore, these lesions have significant impact on the health status of patients. Objective: The aim of this study is to optimize the treatment for skeletally immature patients with an osteochondral lesion. The hypothesis is that a period of immobilization and supervised rehabilitation will lead to better clinical and radiological outcomes compared with standard care which is a ''skill-full'' neglect. Study design: Observational comparative study Study population: Skeletally immature children with an osteochondral lesion of the talus diagnosed on CT. Intervention: Patients in the intervention group will undergo an 8-week period of casting and walking on crutches. Afterwards, they will receive a protocolled period of rehabilitation under supervision of a physical therapist. The control group will have the standard care as treatment. Main study parameters/endpoints: the main study outcome is the difference between the two groups on the OxAFQ-C. Secondary study outcomes are radiologic changes in terms of morphology and lesion size, NRS during weight bearing and quality of life measured with a Peds-QL, EQ-5D-y and AAS. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: the burden that patients will have is mainly the time that they have to spent on fulfilling the questionnaires.

Participants needed: 76
Trial details
Age: 4-18Biological sex: AllType: InterventionalSponsor: Tristan BuckUpdated: Jan 24, 2024Locations: 2
Eligibility criteria

Symptomatic, osteochondral lesion of the talus [+3]

acute traumatic lesions [+2]